Cargando…
A Case of Acute Pericarditis After COVID-19 Vaccination
A two-dose regimen of Pfizer–BioNTech COVID-19 vaccination confers 95% protection against COronaVIrus Disease 19 (COVID-19) and the safety profile is adequate. To the submission date, there were no reports in literature of acute pericarditis after BNT162b2 vaccination. However, pericarditis has been...
Autores principales: | Sonaglioni, Andrea, Albini, Adriana, Noonan, Douglas M., Brucato, Antonio, Lombardo, Michele, Santalucia, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974729/ https://www.ncbi.nlm.nih.gov/pubmed/35387019 http://dx.doi.org/10.3389/falgy.2021.733466 |
Ejemplares similares
-
Case Report: An Unusual Case of Biventricular Thrombosis in a COVID-19 Patient With Ischemic Dilated Cardiomyopathy: Assessment of Mass Mobility and Embolic Risk by Tissue Doppler Imaging
por: Sonaglioni, Andrea, et al.
Publicado: (2021) -
High-risk pulmonary embolism in a post-COVID 19 female under hormonal contraception
por: Sonaglioni, Andrea, et al.
Publicado: (2023) -
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period
por: Sonaglioni, Andrea, et al.
Publicado: (2022) -
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
por: AlOtaibi, Ibtihal, et al.
Publicado: (2023) -
COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches
por: Laisuan, Wannada
Publicado: (2021)